To stem the ever-increasing cases of the Coronavirus pandemic, we need diagnostic tests that can be performed quickly, and we need a vaccine. Both research & development endeavors take valuable time. With the advent of a quick COVID-19 diagnostic test, the spread of this pandemic disease can be ameliorated. With the development of a vaccine, further outbreaks can be prevented. Vaccine development requires (1) identification of an immunogenic relevant protein or other relevant component for transmission, (2) manufacture of the relevant antigen(s), (3) testing in animals to show an immune response, B cell or T cell, (4) demonstration that the immune response is protective. MarinBio is ready to help in all these steps.

With the current shortage of quick COVID-19 tests and vaccines, MarinBio is ready to assist in the development to accelerate the timeline for FDA acceptance and distribution. MarinBio scientists have over 25 years of experience helping our clients to develop, qualify and validate viral or cellular protein or RNA/DNA tests as well as a viral enzyme, anti-inflammatory drug potency assay or other quantitative bioassays.

This is an emerging, rapidly evolving situation that MarinBio will provide updated information as it becomes available, in addition to updated guidance. For further information please contact MarinBio at info@marinbio.com or call 415 883 8000 or visit our website at www.marinbio.com